John V. Balen, Director at Cardlytics, Inc. (CDLX), bought 1,000 shares at $89.85 ($90K) on 2021-08-30, disclosed to the SEC on 2021-08-31.
Open-market purchase of $90k CDLX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| CDLX | BUY | 2022-05-31 | $137K | — | Filing → |
| CDLX | BUY | 2022-05-10 | $88K | — | Filing → |
| CDLX | BUY | 2021-08-23 | $160K | — | Filing → |